Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of an undiluted intravenous infusion of I.V.-Hepabig Inj. for hepatitis B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• I.V.-Hepabig Inj.

Snippet

Sponsor: GC Biopharma Corp | Conditions: Hepatitis B | Phase 3 | Status: RECRUITING